Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Oleksandr Pastukhov
Observed name:
Pastukhov, Oleksandr
Institutions:
University of Zurich,
ETH Zurich,
Wyss Zurich Translational Center
Observed institutions:
University of Bern,
University of Zurich,
ETH Zurich,
University Children's Hospital Zurich,
Wyss Zurich Translational Center
ORCID:
0000-0002-0735-7753
Observed ORCID:
0000-0002-0735-7753
OpenAlex ID:
A5010285534
Severe glucose-6-phosphate dehydrogenase deficiency leads to susceptibility to infection and absent NETosis
2016
·
Ulrich Siler
, Susana Romao
, et al.
·
Journal of Allergy and Clinical Immunology
·
85
PDF
The ceramide kinase inhibitor NVP ‐231 inhibits breast and lung cancer cell proliferation by inducing M phase arrest and subsequent cell death
2014
·
Oleksandr Pastukhov
, Stephanie Schwalm
, et al.
·
British Journal of Pharmacology
·
74
PDF
Human DOCK2 Deficiency: Report of a Novel Mutation and Evidence for Neutrophil Dysfunction
2019
·
Leen Moens
, Mieke Gouwy
, et al.
·
Journal of Clinical Immunology
·
49
PDF
Loss of sphingosine kinase‐1 in carcinoma cells increases formation of reactive oxygen species and sensitivity to doxorubicin‐induced DNA damage
2010
·
Andrea Huwiler
, Nataliya Kotelevets
, et al.
·
British Journal of Pharmacology
·
43
The ω3‐polyunsaturated fatty acid derivatives AVX 001 and AVX 002 directly inhibit cytosolic phospholipase A 2 and suppress PGE 2 formation in mesangial cells
2012
·
Andrea Huwiler
, Astrid J Feuerherm
, et al.
·
British Journal of Pharmacology
·
38
PDF
Ceramide Kinase Contributes to Proliferation but not to Prostaglandin E2 Formation in Renal Mesangial Cells and Fibroblasts
2014
·
Oleksandr Pastukhov
, Stephanie Schwalm
, et al.
·
Cellular Physiology and Biochemistry
·
34
PDF
High Levels of IL-18 and IFN-γ in Chronically Inflamed Tissue in Chronic Granulomatous Disease
2019
·
Virginia Meda Spaccamela
, Rocio G. Valencia
, et al.
·
Frontiers in Immunology
·
25
PDF
A Prokaryotic S1P Lyase Degrades Extracellular S1P In Vitro and In Vivo: Implication for Treating Hyperproliferative Disorders
2011
·
Andrea Huwiler
, Florence Bourquin
, et al.
·
PLoS ONE
·
21
PDF
CRISPR-Directed Therapeutic Correction at the NCF1 Locus Is Challenged by Frequent Incidence of Chromosomal Deletions
2020
·
Dominik Wrona
, Oleksandr Pastukhov
, et al.
·
Molecular Therapy — Methods & Clinical Development
·
19
PDF
Inhibitors of secreted phospholipase A2 suppress the release of PGE2 in renal mesangial cells
2016
·
Sofia Vasilakaki
, Efrosini Barbayianni
, et al.
·
Bioorganic & Medicinal Chemistry
·
16
Gene editing of NCF1 loci is associated with homologous recombination and chromosomal rearrangements
2024
·
Federica Raimondi
, Kah Mun Siow
, et al.
·
Communications Biology
·
9
Targeted knock-in of NCF1 cDNA into the NCF2 locus leads to myeloid phenotypic correction of p47 -deficient chronic granulomatous disease
2024
·
Kah Mun Siow
, Merve Güngör
, et al.
·
Molecular Therapy — Nucleic Acids
·
8
Small Peptides Able to Suppress Prostaglandin E2 Generation in Renal Mesangial Cells
2018
·
Sofia Vasilakaki
, Oleksandr Pastukhov
, et al.
·
Molecules
·
7
PDF
Preclinical efficacy and safety of a novel lentiviral vector for ex vivo gene therapy of p47phox-deficient chronic granulomatous disease.
2026
·
Panagiotis Tsapogas
, Oleksandr Pastukhov
, et al.
·
Molecular Therapy
Advances in Gene Therapy for Chronic Granulomatous Disease
2026
·
Kah Mun Siow
, Panagiotis Tsapogas
, et al.
·
Springer eBooks
Show more works
View as search
Works count:
16
Citation count:
428
H-index:
10
I10-index:
10
Year
Topic
Type